Merck KGaA (OTCMKTS:MKKGY) Short Interest Update

Merck KGaA (OTCMKTS:MKKGY) saw a large decline in short interest in the month of January. As of January 30th, there was short interest totaling 120,341 shares, a decline of 34.8% from the January 15th total of 184,605 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 138,732 shares, the short-interest ratio is presently 0.9 days. Based on an average daily volume of 138,732 shares, the short-interest ratio is presently 0.9 days. Approximately 0.0% of the shares of the company are sold short.

Merck KGaA Trading Down 0.4%

Shares of MKKGY opened at $29.83 on Friday. Merck KGaA has a fifty-two week low of $24.32 and a fifty-two week high of $31.00. The business has a 50-day moving average of $29.14 and a 200 day moving average of $27.19. The firm has a market cap of $19.28 billion, a P/E ratio of 11.88, a price-to-earnings-growth ratio of 6.06 and a beta of 0.96. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.97 and a current ratio of 1.49.

Merck KGaA (OTCMKTS:MKKGY) last released its quarterly earnings data on Thursday, November 13th. The company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.54 by $0.27. The business had revenue of $6.17 billion for the quarter, compared to the consensus estimate of $6.08 billion. Merck KGaA had a net margin of 13.92% and a return on equity of 10.07%. As a group, research analysts forecast that Merck KGaA will post 1.87 EPS for the current year.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft downgraded shares of Merck KGaA from a “buy” rating to a “hold” rating in a report on Tuesday, February 3rd. Three analysts have rated the stock with a Hold rating, According to MarketBeat, Merck KGaA currently has a consensus rating of “Hold”.

About Merck KGaA

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.